Form 8-K - Current report:
SEC Accession No. 0001437749-26-013641
Filing Date
2026-04-28
Accepted
2026-04-28 16:02:05
Documents
14
Period of Report
2026-04-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nrc20260424_8k.htm   iXBRL 8-K 31333
2 EXHIBIT 99.1 ex_950648.htm EX-99.1 245717
7 nrclogo.jpg GRAPHIC 6353
  Complete submission text file 0001437749-26-013641.txt   433159

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nrc-20260428.xsd EX-101.SCH 3571
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nrc-20260428_def.xml EX-101.DEF 11421
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nrc-20260428_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nrc-20260428_pre.xml EX-101.PRE 11581
17 EXTRACTED XBRL INSTANCE DOCUMENT nrc20260424_8k_htm.xml XML 2830
Mailing Address 1245 Q STREET LINCOLN NE 68508
Business Address 1245 Q STREET LINCOLN NE 68508 4024752525
NRC HEALTH (Filer) CIK: 0000070487 (see all company filings)

EIN.: 470634000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35929 | Film No.: 26907483
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)